## Abstract Because of clinical similarities, benign hereditary chorea and myoclonus‐dystonia (DYT11) might be confused. No systematic comparisons of genetically proven cases with thyroid transcription factor‐1 (__TITF‐1__) and ε‐sarcoglycan (__SGCE__) mutations have been performed to date. Three i
Benign hereditary chorea: Clinical, genetic, and pathological findings
✍ Scribed by Galit Kleiner-Fisman; Ekaterina Rogaeva; William Halliday; Sylvain Houle; Toshitaka Kawarai; Christine Sato; Helena Medeiros; Peter H. St. George-Hyslop; Anthony E. Lang
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 390 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Benign hereditary chorea is an autosomal dominant disorder presenting with childhood‐onset chorea, no dementia, and little or no progression. We present a family with typical clinical features of benign hereditary chorea. Pathological investigation of the brain of an affected family member who died of an unrelated condition showed no significant gross or histological abnormalities. Genetic evaluation showed a novel single nucleotide substitution of intron 2 of the TITF‐1 gene (also referred to as TTF, NKX2.1, and T/ebp) on chromosome 14 which is predicted to have drastic consequences on the maturation processes of TITF‐1. Ann Neurol 2003
📜 SIMILAR VOLUMES
## Abstract Benign hereditary chorea is an autosomal dominant disorder characterized by early onset nonprogressive chorea, caused by mutations of the __thyroid transcription factor‐1 (TITF‐1)__ gene. Clinical heterogeneity has been reported and thyroid and respiratory abnormalities may be present.
## Abstract We report a nonconsanguineous family in whom two (of three) sons developed isolated chorea in early childhood, suggesting a diagnosis of benign hereditary chorea (BHC). However, cerebellar ataxia and oculomotor apraxia, without telangiectasia, subsequently developed. Chromosome analysis